Edap TMS SA (EDAP)
7.14
-0.20
(-2.72%)
USD |
NASDAQ |
May 03, 16:00
7.28
+0.14
(+1.96%)
Pre-Market: 20:00
Edap TMS Max Drawdown (5Y): 70.31% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 70.31% |
March 31, 2024 | 70.31% |
February 29, 2024 | 70.31% |
January 31, 2024 | 70.31% |
December 31, 2023 | 70.31% |
November 30, 2023 | 70.31% |
October 31, 2023 | 70.31% |
September 30, 2023 | 74.71% |
August 31, 2023 | 74.71% |
July 31, 2023 | 74.71% |
June 30, 2023 | 74.71% |
May 31, 2023 | 74.71% |
April 30, 2023 | 74.71% |
March 31, 2023 | 74.71% |
February 28, 2023 | 74.71% |
January 31, 2023 | 74.71% |
December 31, 2022 | 74.71% |
November 30, 2022 | 74.71% |
October 31, 2022 | 74.71% |
September 30, 2022 | 74.71% |
August 31, 2022 | 74.71% |
July 31, 2022 | 74.71% |
June 30, 2022 | 74.71% |
May 31, 2022 | 74.71% |
April 30, 2022 | 74.71% |
Date | Value |
---|---|
March 31, 2022 | 74.71% |
February 28, 2022 | 74.71% |
January 31, 2022 | 74.71% |
December 31, 2021 | 74.71% |
November 30, 2021 | 74.71% |
October 31, 2021 | 74.71% |
September 30, 2021 | 74.71% |
August 31, 2021 | 74.71% |
July 31, 2021 | 74.71% |
June 30, 2021 | 74.71% |
May 31, 2021 | 74.71% |
April 30, 2021 | 74.71% |
March 31, 2021 | 74.71% |
February 28, 2021 | 74.71% |
January 31, 2021 | 74.71% |
December 31, 2020 | 74.71% |
November 30, 2020 | 74.71% |
October 31, 2020 | 74.71% |
September 30, 2020 | 74.71% |
August 31, 2020 | 74.71% |
July 31, 2020 | 74.71% |
June 30, 2020 | 74.71% |
May 31, 2020 | 74.71% |
April 30, 2020 | 74.71% |
March 31, 2020 | 74.71% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
70.31%
Minimum
Oct 2023
81.43%
Maximum
May 2019
74.56%
Average
74.71%
Median
Sep 2019
Max Drawdown (5Y) Benchmarks
Biophytis SA | -- |
DBV Technologies SA | 97.67% |
Cellectis SA | 97.08% |
Genfit SA | 88.42% |
Biodexa Pharmaceuticals Plc | 100.00% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -2.022 |
Beta (5Y) | 0.6487 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 59.14% |
Historical Sharpe Ratio (5Y) | 0.088 |
Historical Sortino (5Y) | 0.1505 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 22.03% |